GSS23743: UK Research and Innovation (UKRI) - Antibodies Framework

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-040399-2023-09-26T08:45:30+01:00",
    "date": "2023-09-26T08:45:30+01:00",
    "ocid": "ocds-h6vhtk-040399",
    "description": "The Terms and Conditions for this requirement are available to view on Contracts Finder www.contractsfinder.service.gov.uk it is to be noted that there is no commitment at this stage that the above mentioned opportunity will proceed in its current format.",
    "initiationType": "tender",
    "tender": {
        "id": "GSS23743",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "GSS23743: UK Research and Innovation (UKRI) - Antibodies Framework",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "73111000",
            "description": "Research laboratory services"
        },
        "mainProcurementCategory": "services",
        "description": "***For the avoidance of doubt, this is not a call for competition. This notice is to inform the market of a Future Opportunity*** UK Research and Innovation (UKRI) brings together the seven Research Councils (AHRC, BBSRC, EPSRC, ESRC, MRC, NERC, STFC) plus Innovate UK and a new organisation, Research England. UKRI wishes to establish a Framework for the provision of Antibodies. It is intended that the Framework will be based upon four LOTS: LOT 1 - Primary Unconjugated LOT 2 - Primary Conjugated LOT 3 - Secondary Unconjugated LOT 4 - Secondary Conjugated The objective of this procurement will be to: a) Produce a Framework Agreement that UKRI can easily use and provide a compliant route to market. b) Capture a large percentage of the Antibodies requirements from large value items to low value, high volume items. c) Develop strong relationships with UKRI and Suppliers to ensure that the requirements are captured and value for money is achieved. d) To capture quality management information that will support informed decision making in future procurements. e) To ensure sustainability aspects are considered and integrated into the Framework Agreement. f) To continuously improve and apply best practice procurement that meets the end users' requirements. ****There is no commitment at this stage that the above mentioned opportunity will proceed in its current format**** ***GSS23743 Supplier Day*** In order for Suppliers to obtain an overview of the requirement, UK SBS on behalf of UKRI will be holding a Supplier day on Tuesday 10th October 2023 at 15:00hrs GMT, and Wednesday 11th October 2023 at 14:00hrs GMT. The duration of the Supplier day will be approximately 1 hour and will be held online. If you wish to attend, please complete the attached form: https://forms.office.com/e/xvtvVt4wce confirming your attendance and select your preferred date no later than Friday 6th October 2023 at 14:00hrs GMT. Please note that a maximum of two representatives per organisation is permitted. Following confirmation of attendance, a link to the supplier day will be shared with confirmed attendees. Any information supplied shall not place any supplier at an advantage in a potential procurement process.",
        "value": {
            "amount": 9600000,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "title": "LOT 1 - Primary Unconjugated",
                "description": "UKRI wish to put in place a Framework for the provision of Primary Unconjugated Antibodies",
                "status": "planned"
            },
            {
                "id": "2",
                "title": "LOT 2 - Primary Conjugated",
                "description": "UKRI wish to put a Framework in place for the provision of Primary Conjugated Antibodies",
                "status": "planned"
            },
            {
                "id": "3",
                "title": "LOT 3 - Secondary Unconjugated",
                "description": "UKRI wish to put in place a Framework for the provision of Secondary Unconjugated Antibodies",
                "status": "planned"
            },
            {
                "id": "4",
                "title": "LOT 4 - Secondary Conjugated",
                "description": "UKRI wish to put in place a Framework for the provision of Secondary Conjugated Antibodies",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "24000000",
                        "description": "Chemical products"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33140000",
                        "description": "Medical consumables"
                    },
                    {
                        "scheme": "CPV",
                        "id": "71900000",
                        "description": "Laboratory services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            },
            {
                "id": "2",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "24000000",
                        "description": "Chemical products"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33140000",
                        "description": "Medical consumables"
                    },
                    {
                        "scheme": "CPV",
                        "id": "71900000",
                        "description": "Laboratory services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "2"
            },
            {
                "id": "3",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "24000000",
                        "description": "Chemical products"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33140000",
                        "description": "Medical consumables"
                    },
                    {
                        "scheme": "CPV",
                        "id": "71900000",
                        "description": "Laboratory services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "3"
            },
            {
                "id": "4",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "24000000",
                        "description": "Chemical products"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33140000",
                        "description": "Medical consumables"
                    },
                    {
                        "scheme": "CPV",
                        "id": "71900000",
                        "description": "Laboratory services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "4"
            }
        ],
        "communication": {
            "futureNoticeDate": "2023-12-06T00:00:00Z"
        },
        "coveredBy": [
            "GPA"
        ]
    },
    "parties": [
        {
            "id": "GB-FTS-87633",
            "name": "UK Research and Innovation",
            "identifier": {
                "legalName": "UK Research and Innovation",
                "noIdentifierRationale": "notOnAnyRegister"
            },
            "address": {
                "streetAddress": "Polaris House, North Star Avenue",
                "locality": "SWINDON",
                "region": "UK",
                "postalCode": "SN21UH",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Goods and Self Service",
                "email": "coreservices@uksbs.co.uk"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "url": "http://www.uksbs.co.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "description": "Research"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-87633",
        "name": "UK Research and Innovation"
    },
    "language": "en"
}